Results 231 to 240 of about 93,749 (369)

Clinical characteristics and outcome in 15 dogs treated with transsphenoidal hypophysectomy for nonfunctional sellar masses

Veterinary Surgery, Volume 52, Issue 1, Page 69-80, January 2023., 2023
Abstract Objective To characterize the clinical features, neurological examination findings, diagnostic imaging results, histopathological findings, and outcome following transsphenoidal hypophysectomy (TSH) in dogs with nonfunctional sellar masses (NFSM). Study design Multi‐institutional retrospective study.
Brittany R. Hyde, Linda G. Martin, Annie V. Chen, Sarah C. Guess, Sheila Carrera‐Justiz, David Bruyette, Tina J. Owen   +6 more
wiley   +1 more source

Editorial: Prognostic factors in pituitary tumors: clinical, biochemical, imaging, and pathological aspects. [PDF]

Front Endocrinol (Lausanne)
Tateno T, Dumitriu Stan RI, Du Four S.
europepmc   +1 more source

Pituitary-like proopiomelanocortin transcripts in human Leydig cell tumors. [PDF]

, 1990
Yves de Keyzer, Frédéric Lenne, J F Massias, Didier Vieau, J P Luton, A Kahn, Xavier Bertagna   +6 more
openalex   +1 more source

Genocopy of EVI1‐AML with paraneoplastic diabetes insipidus: PRDM16 overexpression by t(1;2)(p36;p21) and enhancer hijacking

British Journal of Haematology, EarlyView.
Summary Diabetes insipidus (DI) in patients with acute myeloid leukaemia (AML) and chromosome 3q alterations (EVI1/PRDM3/MECOM overexpression) constitutes a poorly understood paraneoplasia. A 44‐year‐old patient presented with clinical and morphological features of this syndrome but, surprisingly, disclosed the rare translocation t(1;2)(p36;p21), with ...
Julian List, Etienne Sollier, Fiona Brown‐Burke, Katherine Kelly, Dietmar Pfeifer, Valeria Shlyakhto, Kristina Maas‐Bauer, Milena Pantic, Christoph Plass, Michael Lübbert   +9 more
wiley   +1 more source

Expression of MMP-2, MMP-9 and TIMP-2 in pituitary tumors and their relationship with cavernous sinus invasion. [PDF]

Endocr Oncol
Thé B Freire AC, Jallad RS, Batista RL, Glezer A, Machado MC, Ochman G, Cescato VA, Cunha Neto MBC, Frassetto FP, de Medeiros RSS, Trarbach EB.   +10 more
europepmc   +1 more source

Markers of Aggressiveness in Pituitary Tumors: Update and Perspectives. [PDF]

J Clin Med, 2022
Bioletto F, Berton AM, Prencipe N, Varaldo E, Bona C, Grottoli S.   +5 more
europepmc   +1 more source

A Cyproheptadine-Reversible Defect in ACTH Control Persisting after Removal of the Pituitary Tumor in Cushing's Disease

, 1981
Harvey V. Lankford, Henry St. George Tucker, William G. Blackard   +2 more
openalex   +2 more sources

The dark sides of the GPCR tree ‐ research progress on understudied GPCRs

British Journal of Pharmacology, EarlyView.
Abstract A large portion of the human GPCRome is still in the dark and understudied, consisting even of entire subfamilies of GPCRs such as odorant receptors, class A and C orphans, adhesion GPCRs, Frizzleds and taste receptors. However, it is undeniable that these GPCRs bring an untapped therapeutic potential that should be explored further.
Magdalena M. Scharf, Laura J. Humphrys, Sandra Berndt, Antonella Di Pizio, Juliane Lehmann, Ines Liebscher, Alessandro Nicoli, Masha Y. Niv, Lior Peri, Hannes Schihada, Gunnar Schulte   +10 more
wiley   +1 more source

Posterior pituitary tumors and other rare entities involving the pituitary gland. [PDF]

Brain Pathol
Roncaroli F, Giannini C.
europepmc   +1 more source

The expression of glucocorticoid and mineralocorticoid receptors in pituitary tumors causing Cushing's disease and silent corticotroph tumors. [PDF]

Front Endocrinol (Lausanne), 2023
Kober P, Rusetska N, Mossakowska BJ, Maksymowicz M, Pękul M, Zieliński G, Styk A, Kunicki J, Działach Ł, Witek P, Bujko M.   +10 more
europepmc   +1 more source